Skip to content

Clinical trials

Phase 2 Multiple Sclerosis trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 2 Country / region: Russia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20062
20072
20081
20094
20105
20112
20121
20133
20141
20151
20161
20171
20181
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated5
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen5
Novartis Pharmaceuticals5
GlaxoSmithKline3
Actelion2
EMD Serono2
GeNeuro SA2
Sanofi2
Avigen1
Biocad1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis30
Multiple Sclerosis, Relapsing-Remitting14
Demyelinating Diseases2
Multiple Sclerosis, Chronic Progressive2
Muscle Spasticity2
Recurrence2
Autoimmune Diseases1
Diffuse Cerebral Sclerosis of Schilder1
Immune System Diseases1
Nervous System Diseases1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.